EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Structure, function, regulation, evolution, and therapeutic implications of PARP14

Pulak Kar, Nina Đukić, Dragana Ahel, Ivan Ahel

Genes & Development · 01.06.2026 · 40 (11-12) · 780-795

DOI: 10.1101/gad.353495.125 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Genes & Development, online erschienen am 06.03.2026. Verfasst von Pulak Kar und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biological Sciences, Sri Ramaswamy Memorial University-Andhra Pradesh, Amaravati 522240, India; ivan.ahel@path.ox.ac.uk pulak.k@srmap.e…. Hauptthemen laut MEDLINE: Poly(ADP-ribose) Polymerases, Evolution, Molecular. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 155 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Wellcome Trust, Biotechnology and Biological Sciences Research Council, Cancer Research UK.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

ADP-ribosylation (ADPr) is a posttranslational modification conserved across all domains of life that regulates a wide variety of processes. Among ADP-ribosyl transferases (ARTs) in humans, PARP14 has emerged as a key regulator involved in antiviral defense, inflammation, and DNA damage response. Recent studies have uncovered its dynamic and versatile roles in modulating DNA replication stress and DNA repair, positioning it at the intersection of genomic stability and immune regulation. Despite growing insights into its molecular functions, many aspects of PARP14-mediated signaling remain elusive. In this perspective, we explore the fundamental and emerging biological features of PARP14, highlighting its structure, function, evolution, and roles in cellular homeostasis and disease. Additionally, we discuss recent advances in targeting PARP14 for therapeutic intervention, particularly in oncology and immunology. A deeper mechanistic understanding of PARP14 function may inform the development of novel therapeutic strategies that exploit its regulatory network for clinical benefit.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Poly(ADP-ribose) PolymerasesEvolution, MolecularHumansAnimalsDNA RepairADP-RibosylationDNA DamageSignal Transduction

Stichwörter der Autor:innen

ADP-ribosylationDNA damagePARPinfectioninterferon signalingubiquitin

Substanzen

Poly(ADP-ribose) PolymerasesPARP14 protein, human

Autor:innen und Institutionen

  • Department of Biological Sciences, Sri Ramaswamy Memorial University-Andhra Pradesh, Amaravati 522240, India; ivan.ahel@path.ox.ac.uk pulak.k@srmap.edu.in.
  • Sir William Dunn School of Pathology, University of Oxford, Oxford OX1 3RE, United Kingdom.
  • Sir William Dunn School of Pathology, University of Oxford, Oxford OX1 3RE, United Kingdom ivan.ahel@path.ox.ac.uk pulak.k@srmap.edu.in.

Förderung

  • Wellcome Trust
  • Biotechnology and Biological Sciences Research Council
  • Cancer Research UK

Zitieren

APA

Kar, P., Đukić, N., Ahel, D., & Ahel, I. (2026). Structure, function, regulation, evolution, and therapeutic implications of PARP14. Genes & Development, 40(11-12), 780-795. https://doi.org/10.1101/gad.353495.125

Vancouver

Kar P, Đukić N, Ahel D, Ahel I. Structure, function, regulation, evolution, and therapeutic implications of PARP14. Genes & Development. 2026;40(11-12):780-795. doi:10.1101/gad.353495.125

BibTeX
@article{Kar2026,
  author = {Kar, Pulak and Đukić, Nina and Ahel, Dragana and Ahel, Ivan},
  title = {Structure, function, regulation, evolution, and therapeutic implications of PARP14},
  journal = {Genes & Development},
  year = {2026},
  volume = {40},
  number = {11-12},
  pages = {780--795},
  doi = {10.1101/gad.353495.125}
}
Kostenlos starten →